ArticleEuropean child & adolescent psychiatry2016

Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed.

Pieter J Hoekstra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.